Aspen Receives US $1 Million In Transfer of Technology Agreement
Johannesburg – Eli Lilly today announced the US$1 million milestone payment to Aspen, South Africa’s leading pharmaceutical manufacturer, as part of the joint collaboration on
Transactions
Aspen’s S26 Assurance of Quality
A message from Aspen Group Chief Executive, Stephen Saad, to the mothers of South Africa’s babies: “At Aspen we understand that the wellbeing of your baby
Quality of S-26 in South Africa Guaranteed
Johannesburg: Aspen Nutritionals, manufacturer of S-26 and other infant milk formulations (IMFs), confirms that all IMFs manufactured and marketed by Aspen Nutritionals are safe for
Official statement regarding the alleged purchase transactions entered into between Aspen and Frankel Chemicals
OFFICIAL STATEMENT REGARDING THE ALLEGED PURCHASE TRANSACTIONS ENTERED INTO BETWEEN ASPEN AND FRANKEL CHEMICALS FOR THE PURCHASE BY ASPEN FROM FRANKEL CHEMICALS OF RAW MATERIALS
Aspen and GSK agree on Strategic Deals
Press Conference Presentation <Click to download> SENS Announcement <Click to download> The Transactions comprise: The acquisition of the rights to distribute GSK products in South
Aspen Matrix Release
Aspen Pharmacare Holdings Limited (“Aspen”) and Matrix Laboratories Limited (“Matrix”) of the Republic of India, would like to announce the divestment of the existing joint
Revision of Terms of Aspen`s Investment in Strides` Latin American Operations
Further to the announcement made on 20 November 2007, Aspen is pleased to announce that its wholly owned subsidiary, Aspen Global Incorporated (“Global”) has agreed
Aspen Businesses in Licensing Deal With GSK
Johannesburg – JSE listed Aspen Pharmacare Holdings Limited (Apn) has announced today that it has entered into licensing and supply agreements with leading multinational pharmaceutical
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
